1. Home
  2. DOMO vs ENLV Comparison

DOMO vs ENLV Comparison

Compare DOMO & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Domo Inc. Class B

DOMO

Domo Inc. Class B

HOLD

Current Price

$3.91

Market Cap

132.7M

Sector

Technology

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$2.07

Market Cap

149.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOMO
ENLV
Founded
2010
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
132.7M
149.0M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
DOMO
ENLV
Price
$3.91
$2.07
Analyst Decision
Buy
Buy
Analyst Count
9
2
Target Price
$10.28
$20.00
AVG Volume (30 Days)
2.2M
226.1K
Earning Date
05-20-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
31.92
N/A
EPS
N/A
N/A
Revenue
$318,857,000.00
N/A
Revenue This Year
$3.41
N/A
Revenue Next Year
$4.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.57
N/A
52 Week Low
$1.84
$0.43
52 Week High
$18.49
$7.64

Technical Indicators

Market Signals
Indicator
DOMO
ENLV
Relative Strength Index (RSI) 56.51 40.46
Support Level $3.22 $0.77
Resistance Level $3.99 $7.64
Average True Range (ATR) 0.28 0.40
MACD 0.02 -0.36
Stochastic Oscillator 50.77 5.48

Price Performance

Historical Comparison
DOMO
ENLV

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: